SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-018022
Filing Date
2019-05-09
Accepted
2019-05-09 16:21:37
Documents
66
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fgen-10q_20190331.htm 10-Q 2690445
2 EX-10.26XXXVI fgen-ex1026xxxvi_150.htm EX-10.26XXXVI 26058
3 EX-31.1 fgen-ex311_8.htm EX-31.1 8310
4 EX-31.2 fgen-ex312_6.htm EX-31.2 8348
5 EX-32.1 fgen-ex321_7.htm EX-32.1 7830
  Complete submission text file 0001564590-19-018022.txt   9131993

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fgen-20190331.xml EX-101.INS 2162521
7 XBRL TAXONOMY EXTENSION SCHEMA fgen-20190331.xsd EX-101.SCH 59617
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fgen-20190331_cal.xml EX-101.CAL 75602
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fgen-20190331_def.xml EX-101.DEF 198078
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20190331_lab.xml EX-101.LAB 433145
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20190331_pre.xml EX-101.PRE 356818
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 19810871
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences